Nickolai A. Barlev

1.8k citations
61 papers · 1.4k indexed · h-index 19
Topics
Ubiquitin and proteasome pathways (14 papers)Cancer-related Molecular Pathways (14 papers)Epigenetics and DNA Methylation (7 papers)

In The Last Decade

Nickolai A. Barlev

58 papers receiving 1.4k citations

Peers

Nickolai A. Barlev
Comparison fields: 5 of 100
  • Molecular Biology 832
  • Oncology 316
  • Cancer Research 207
  • Immunology 174
  • Physiology 144
Replace Shin‐Il Kim with:
Shin‐Il Kim South Korea
Jing Jiang China
Tinghe Yu China
Iring Heisler Germany
Hojjatollah Nozad Charoudeh Iran
Jong‐Seo Kim South Korea
Francesca Buricchi Italy
Fabio Gasparri Italy
Fang Sun China
Jintang He United States
Nickolai A. Barlev relative to Shin‐Il Kim South Korea Shin‐Il Kim's profile →
Citations per field
00.5×
Shin‐Il Kim · 1×
Citations per year

Countries citing papers authored by Nickolai A. Barlev

Since Specialization
Citations

This map shows the geographic impact of Nickolai A. Barlev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nickolai A. Barlev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nickolai A. Barlev more than expected).

Fields of papers citing papers by Nickolai A. Barlev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nickolai A. Barlev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nickolai A. Barlev. The network helps show where Nickolai A. Barlev may publish in the future.

Co-authorship network of co-authors of Nickolai A. Barlev

This figure shows the co-authorship network connecting the top 25 collaborators of Nickolai A. Barlev. A scholar is included among the top collaborators of Nickolai A. Barlev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nickolai A. Barlev. Nickolai A. Barlev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 4
5 7
6 3
7 4
8 14
9 16
10 10
11 14
12 26
13 139
14 15
15 1
16 48
17 22
18 3
19 2
20 137

About Nickolai A. Barlev

Nickolai A. Barlev is a scholar working on Oncology, Biotechnology and Molecular Biology, having authored 61 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (14 papers), Cancer-related Molecular Pathways (14 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Aging (30 citations), Cancer Research (207 citations) and Molecular Biology (832 citations). Nickolai A. Barlev has collaborated with scholars based in Russia, United Kingdom and Kazakhstan. Frequent co-authors include Gerry Melino, Larissa Lezina, Alexandra Daks, Alexey V. Antonov, Olga Fedorova, Alexey Petukhov, A. V. Garabadgiu, Oleg Shuvalov, Dmitri Tentler and Yuan Yan. Their work appears in journals such as Nano Letters, Molecular Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026